Also trades as: 0K1R.L (LSE) · $vol 0M
VRDN NASDAQ
Viridian Therapeutics, Inc.
1W: +1.5%
1M: +23.4%
3M: -35.5%
YTD: -42.3%
1Y: +28.0%
3Y: -24.5%
5Y: +1.6%
$17.24
-0.45 (-2.54%)
Weekly Expected Move ±18.1%
$11
$14
$17
$20
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026270
Institutions Holding
+26 vs prior
106.2%
Ownership
-102.99%
43
New
71
Increased
131
Reduced
78
Closed
👔 Insider Trades
8 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-03-03 | Beetham Thomas W. | officer: chief operating officer | F-Tax Withholding | 3,138 | $29.32 | $92K | Filing |
| 2026-03-03 | Harmon Seth | officer: chief financial officer | F-Tax Withholding | 2,091 | $29.32 | $61K | Filing |
| 2026-03-03 | Mahoney Stephen F. | officer: president and ceo | F-Tax Withholding | 7,627 | $29.32 | $224K | Filing |
| 2026-03-03 | Tousignant Jennifer | officer: chief legal officer | F-Tax Withholding | 1,724 | $29.32 | $51K | Filing |
| 2025-12-31 | Tousignant Jennifer | officer: chief legal officer | S-Sale | 2,272 | $31.16 | $71K | Filing |
| 2025-10-23 | Fairmount Funds Management LLC | director | P-Purchase | 454,545 | $22.00 | $10.0M | Filing |
| 2025-10-23 | Fairmount Healthcare Fund II GP LLC | director | P-Purchase | 454,545 | $22.00 | $10.0M | Filing |
| 2025-10-23 | Fairmount Healthcare Fund II L.P. | director | P-Purchase | 454,545 | $22.00 | $10.0M | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 15,379,377 | $301M | +994,921 | 2026-03-31 | Filing |
| BlackRock, Inc. | 7,831,475 | $153M | +1,399,552 | 2026-03-31 | Filing |
| STATE STREET CORP | 4,672,885 | $91M | +1,206,325 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,167,201 | $82M | +4,167,201 | 2026-03-31 | Filing |
| Fairmount Funds Management LLC | 3,914,458 | $77M | — | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 3,148,893 | $62M | +1,705,791 | 2026-03-31 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 3,078,554 | $60M | +1,107,143 | 2026-03-31 | Filing |
| Kynam Capital Management, LP | 2,341,652 | $46M | +871,111 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,333,213 | $46M | +341,039 | 2026-03-31 | Filing |
| Balyasny Asset Management L.P. | 2,315,957 | $45M | +1,812,089 | 2026-03-31 | Filing |
| TANG CAPITAL MANAGEMENT LLC | 1,792,626 | $35M | — | 2026-03-31 | Filing |
| Fisher Asset Management, LLC | 1,768,295 | $35M | -11,989 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,641,477 | $32M | +1,641,477 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 1,591,945 | $31M | +327,898 | 2026-03-31 | Filing |
| Avoro Capital Advisors LLC | 1,500,000 | $29M | — | 2026-03-31 | Filing |
| Deep Track Capital, LP | 1,393,944 | $27M | -1,130,889 | 2026-03-31 | Filing |
| BANK OF AMERICA CORP /DE | 1,163,615 | $23M | +173,498 | 2026-03-31 | Filing |
| DEUTSCHE BANK AG | 1,032,316 | $20M | +552,558 | 2026-03-31 | Filing |
| JPMORGAN CHASE & CO | 1,059,864 | $20M | +49,604 | 2026-03-31 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 970,018 | $19M | +180,000 | 2026-03-31 | Filing |